Wenjun Wang

Changchun, 130033, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Author Correction: Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway.

Author Correction: Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway.

Journal: Scientific reports

Published: October 10, 2024

Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway.

Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway.

Journal: Scientific reports

Published: March 18, 2024

Retraction notice to "Salidroside protects ATDC5 cells against lipopolysaccharide-induced injury through up-regulation of microRNA-145 in osteoarthritis" [Int. Immunopharmacol. 67 (2019) 441-448].

Retraction notice to "Salidroside protects ATDC5 cells against lipopolysaccharide-induced injury through up-regulation of microRNA-145 in osteoarthritis" [Int. Immunopharmacol. 67 (2019) 441-448].

Journal: International immunopharmacology

Published: May 02, 2021

Silencing hsa_circRNA_0008035 exerted repressive function on osteosarcoma cell growth and migration by upregulating microRNA-375.

Silencing hsa_circRNA_0008035 exerted repressive function on osteosarcoma cell growth and migration by upregulating microRNA-375.

Journal: Cell cycle (Georgetown, Tex.)

Published: August 12, 2020

K-RasG12V/Y40C-PI3K/AKT pathway regulates H1.4S35ph through PKA to promote the occurrence and development of osteosarcoma cancer.

K-RasG12V/Y40C-PI3K/AKT pathway regulates H1.4S35ph through PKA to promote the occurrence and development of osteosarcoma cancer.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: May 26, 2019

Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1.

Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: April 04, 2019

Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma.

Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma.

Journal: Journal of bone oncology

Published: April 02, 2019

Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway.

Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway.

Journal: Journal of cellular physiology

Published: November 29, 2018

Salidroside protects ATDC5 cells against lipopolysaccharide-induced injury through up-regulation of microRNA-145 in osteoarthritis.

Salidroside protects ATDC5 cells against lipopolysaccharide-induced injury through up-regulation of microRNA-145 in osteoarthritis.

Journal: International immunopharmacology

Published: August 29, 2018

Association between genetic variants in p53 binding sites and risks of osteosarcoma in a Chinese population: a two-stage case-control study.

Association between genetic variants in p53 binding sites and risks of osteosarcoma in a Chinese population: a two-stage case-control study.

Journal: Cancer biology & therapy

Published: March 30, 2018

Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling.

Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling.

Journal: Journal of bone oncology

Published: December 06, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026